Dr. HUB

Dr. HUB

Views:
60,317
Subscribers:
2,700
Videos:
5,410
Duration:
9:14:10:53

Dr. HUB is a YouTube channel which has more than 2.7 thousand subscribers, with his content totaling roughly 60.32 thousand views views across roughly 5.41 thousand videos.

Created on ● Channel Link: https://www.youtube.com/channel/UCKRl547ofWXId71WM056Z8w





All Videos by Dr. HUB



PublishedVideo TitleDurationViewsCategoryGame
2025-07-29Haemostatic disorders and lab findings - part 10:005
2025-07-29Acute myocardial infarction morphological changes - part 40:000
2025-07-29Von Willebrand disease - part 20:001
2025-07-29Acute myocardial infarction morphological changes - part 30:001
2025-07-29Von Willebrand disease - part 10:001
2025-07-29Acute myocardial infarction morphological changes - part 20:000
2025-07-29Factors affecting iron absorption0:001
2025-07-29Acute myocardial infarction morphological changes - part 10:001
2025-07-28Burkitts lymphoma - part 30:001
2025-07-27Anemia - morphological classification part 20:000
2025-07-27Modified dukes criteria infective endocarditis 2023 - part 30:000
2025-07-27Anemia - morphological classification part 10:000
2025-07-27Modified dukes criteria infective endocarditis 2023 - part 20:000
2025-07-26Stains in pathology0:000
2025-07-26Modified dukes criteria infective endocarditis 2023 - part 10:000
2025-07-26Tumor markers - part 30:000
2025-07-26Radiosensitive and radioresistant tumors0:000
2025-07-26Tumor markers - part 20:000
2025-07-26Vasculitis - modified chapel hill classification part 20:001
2025-07-26Tumor markers - part 10:000
2025-07-26Vasculitis - modified chapel hill classification part 10:001
2025-07-25Macrophages and site0:000
2025-07-25Vasculitis and their sites - part 20:000
2025-07-25Immune cell and associated antigens0:000
2025-07-25Histopathology named cells - part 20:000
2025-07-25Vasculitis and their sites - part 10:000
2025-07-25Systematic lupus erythematosus SLE - characteristic findings part 20:001
2025-07-24Type 2 antibody mediated hypersensitivity - part 20:000
2025-07-24Central nervous system tumours and their histopathological findings - part 50:000
2025-07-24Type 2 antibody mediated hypersensitivity - part 30:000
2025-07-24Histopathology named cells - part 10:000
2025-07-24Systematic lupus erythematosus SLE - characteristic findings part 10:000
2025-07-24Type 2 antibody mediated hypersensitivity - part 10:000
2025-07-24Central nervous system tumours and their histopathological findings - part 40:000
2025-07-24Non HLA genes associated with autoimmune diseases - part 20:002
2025-07-24Central nervous system tumours and their histopathological findings - part 30:000
2025-07-23Central nervous system tumours and their histopathological findings - part 20:000
2025-07-23Transplant rejection reactions - part 40:000
2025-07-23Central nervous system tumours and their histopathological findings - part 10:001
2025-07-23Non HLA genes associated with autoimmune diseases - part 10:000
2025-07-23Staining pattern and antigens - part 20:000
2025-07-22Neurocutaneous syndromes - part 60:001
2025-07-21Pathological named bodies - part 40:000
2025-07-21Malignancies and translocations - part 20:000
2025-07-21Pathological named bodies - part 30:000
2025-07-21Malignancies and translocations - part 10:000
2025-07-21Pathological named bodies - part 20:000
2025-07-20Neurocutaneous syndromes - part 10:001
2025-07-20Pathological named bodies - part 10:005
2025-07-20Multiple myeloma and cells - part 20:002
2025-07-20Vacutainers - part 20:000
2025-07-20Multiple myeloma and cells - part 10:000
2025-07-20Vacutainers - part 10:000
2025-07-19Lymphomas and chromosomal translocations0:001
2025-07-18Mallory bodies versus councilman bodies - part 20:000
2025-07-17Hemolytic anaemia classification - part 30:000
2025-07-17Mallory bodies versus councilman bodies - part 10:001
2025-07-17Hemolytic anaemia classification - part 20:001
2025-07-17Inheritance pattern of important diseases - part 50:001
2025-07-17Inheritance pattern of important diseases - part 60:000
2025-07-17Hemostatic disorders and lab findings - part 20:000
2025-07-17Hemolytic anaemia classification - part 10:002
2025-07-16Inheritance pattern of important diseases - part 40:001
2025-07-15Von Willebrand disease - part 10:001
2025-07-15Inheritance pattern of important diseases - part 10:000
2025-07-15Factors affecting Iron absorption0:001
2025-07-15Tumor suppressor gene - part 30:000
2025-07-15Burkitts lymphoma - part 30:000
2025-07-15Burkitts lymphoma - part 20:001
2025-07-15Tumor suppressor gene - part 20:000
2025-07-15Burkitts lymphoma - part 10:001
2025-07-15Tumor suppressor gene - part 10:000
2025-07-15Autoimmune hemolytic anaemia - part 30:000
2025-07-15CK7 and CK20 markers in tumors0:000
2025-07-14Autoimmune hemolytic anaemia - part 20:002
2025-07-14Necrosis vs apoptosis - part 30:000
2025-07-14Autoimmune hemolytic anaemia - part 10:001
2025-07-14Necrosis vs apoptosis - part 20:000
2025-07-14Anaemia - morphological classification part 20:000
2025-07-14Onion eye appearance pathology - part 20:000
2025-07-14Anemia - morphological classification part 10:000
2025-07-14Necrosis vs apoptosis - part 10:000
2025-07-13Stains in pathology0:002
2025-07-13Onion eye appearance pathology - part 10:000
2025-07-13Organisms and selective culture media - part 30:000
2025-07-13Organisms and selective culture media - part 20:000
2025-07-13Tumor markers - part 10:004
2025-07-13Tumor markers - part 30:000
2025-07-13Giant cell types0:001
2025-07-13Granuloma and associated diseases - part 20:000
2025-07-13Tumor markers - part 20:002
2025-07-13Macrophages and site0:000
2025-07-13Immune cells and associated antigens0:000
2025-07-13Granuloma and associated diseases - part 10:000
2025-07-12Histopathology named cells - part 20:001
2025-07-12Vaginal infections - part 20:001
2025-07-12Histopathology named cells - part 10:000
2025-07-12Vaginal infections - part 10:000
2025-07-12Non HLA genes associated with autoimmune diseases - part 20:000
2025-07-12Type 2 antibody mediated hypersensitivity - part 20:001